Hoskin DW - Search Results

1

Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody.

Hoskin DW, Phu T, Makrigiannis AP. Hoskin DW, et al. Int J Immunopharmacol. 1996 Nov;18(11):623-31. doi: 10.1016/s0192-0561(96)00069-0. Int J Immunopharmacol. 1996. PMID: 9089006

2

Expression and utilization of chymotrypsin-like but not trypsin-like serine protease enzymes by nonspecific T killer cells activated by anti-CD3 monoclonal antibody.

Kaiser M, Hoskin DW. Kaiser M, et al. Among authors: hoskin dw. Cell Immunol. 1992 Apr 15;141(1):84-98. doi: 10.1016/0008-8749(92)90129-d. Cell Immunol. 1992. PMID: 1532539

3

Production and characterization of a novel monoclonal antibody inhibitory for murine natural killer cell activity.

Hoskin DW, Roder JC. Hoskin DW, et al. Immunol Invest. 1992 Feb;21(1):11-23. doi: 10.3109/08820139209069359. Immunol Invest. 1992. PMID: 1548044

4

A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells.

Hoskin DW, Stankova J, Anderson SK, Roder JC. Hoskin DW, et al. Int J Cancer. 1989 May 15;43(5):940-8. doi: 10.1002/ijc.2910430536. Int J Cancer. 1989. PMID: 2469657

5

Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.

Stanková J, Hoskin DW, Roder JC. Stanková J, et al. Among authors: hoskin dw. Cell Immunol. 1989 Jun;121(1):13-29. doi: 10.1016/0008-8749(89)90002-6. Cell Immunol. 1989. PMID: 2470516

6

Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies.

Hoskin DW, Stankova J, Anderson SK, Roder JC. Hoskin DW, et al. Cancer Immunol Immunother. 1989;29(3):226-30. doi: 10.1007/BF00200000. Cancer Immunol Immunother. 1989. PMID: 2567211 Free PMC article.

7

Cyclosporin A inhibits 2-chloroadenosine-induced DNA cleavage in mouse thymocytes.

Makrigiannis AP, Blay J, Hoskin DW. Makrigiannis AP, et al. Among authors: hoskin dw. Int J Immunopharmacol. 1994 Dec;16(12):995-1001. doi: 10.1016/0192-0561(94)90078-7. Int J Immunopharmacol. 1994. PMID: 7705972

8

2-Chloroadenosine inhibits the MHC-unrestricted cytolytic activity of anti-CD3-activated killer cells: evidence for the involvement of a non-A1/A2 cell-surface adenosine receptor.

Hoskin DW, Reynolds T, Blay J. Hoskin DW, et al. Cell Immunol. 1994 Nov;159(1):85-93. doi: 10.1006/cimm.1994.1297. Cell Immunol. 1994. PMID: 7954843

9

Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.

MacKenzie WM, Hoskin DW, Blay J. MacKenzie WM, et al. Among authors: hoskin dw. Cancer Res. 1994 Jul 1;54(13):3521-6. Cancer Res. 1994. PMID: 8012976

10

Effect of interferon-gamma, interleukin-2 and interleukin-4 on cyclosporin-A-mediated inhibition of anti-CD3-induced T-lymphocyte proliferation.

Fitzpatrick L, Kaiser M, Stewart BH, Hoskin DW. Fitzpatrick L, et al. Among authors: hoskin dw. Int J Immunopharmacol. 1994 Apr;16(4):289-93. doi: 10.1016/0192-0561(94)90003-5. Int J Immunopharmacol. 1994. PMID: 8045668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters